Wednesday, March 27, 2019 12:44:15 AM
In addition to terpenes and flavonoids, this consists of many other cannabinoids. These include cannabidiol acid (CBDa), cannabidivarin (CBDV), cannabigerol (CBG), cannabinol (CBN), and cannabichromene (CBC).
Each of these compounds has its own unique beneficial traits:
CBDV has been shown to be an effective anticonvulsant.
CBG can work to reduce inflammation.
CBDa is the acidic form of CBD and has been found to have the potential to aid cancer and helps to reduce nausea.
CBN has been found to have sedative properties. It helps aid insomnia and relaxation.
CBD has antifungal properties.
It’s the combination of all of these compounds taken in the full-spectrum hemp oil that provides the best health benefits. When all the compounds work together, this is known as the entourage effect.
Recent ETST News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 08:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:20:11 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/27/2024 01:30:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:05:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 02:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 05:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:59:37 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 11:10:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 11:01:45 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 12:50:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2023 11:08:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 04:51:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 11:16:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 01:01:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 03:41:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/28/2023 01:10:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/27/2023 08:53:38 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM